Private Equity-backed SpiTrex Orthopedics, a frontrunner in global medical device contract manufacturing, has embarked on a transformative journey with its acquisition of Watershed Idea Foundry, a specialist in titanium additive manufacturing (AM). This strategic move positions SpiTrex Orthopedics, established in 2014 and headquartered in Le Locle, to broaden its scope of services by incorporating the cutting-edge technology of 3D printing.
The inception of SpiTrex Orthopedics in 2014 emerged from a pivotal management buyout of a subsidiary of Biomet located in Le Locle. With Ekkio Capital stepping in as an investor in 2019, SpiTrex made its mark on the industry by successfully assimilating two prominent companies in the United States.
The integration of Watershed Idea Foundry into the SpiTrex Orthopedics consortium brings yet another illustrious American entity into the fold. Guided by a philosophy of incessant growth and innovation, the acquisition of Watershed assumes a pivotal role in the expansive vision of SpiTrex. This strategic move bolsters their commitment to offering world-class services, with a distinct focus on the realm of 3D printing. To signify this transition, Watershed undergoes a rebranding and emerges as SpiTrex 3D.
In the words of Matt Burba, CEO of SpiTrex Orthopedics, “The acquisition of Watershed Idea Foundry is a pivotal stride toward realizing SpiTrex Orthopedics’ aspiration to become the premier Contract Development and Manufacturing Organization (CDMO) in the Spine, Trauma, and Extremity market. The burgeoning applications and utilities of Additive Manufacturing make this technology an exciting frontier, compelling SpiTrex to integrate it into our portfolio. Watershed’s profound expertise in Design for Additive Manufacturing, coupled with their FDA Master Files for additive processes, enhances our competitive edge. This positions us as the preferred choice for customers seeking rapid market entry.”
Matt Burba underscores the significance of the Watershed Idea Foundry acquisition, highlighting its role in expanding the repertoire of contract manufacturing services. This extension of capabilities facilitates a comprehensive end-to-end Additive Manufacturing solution. It spans the entire spectrum from research and product development to prototyping, manufacturing, quality assurance, meticulous packaging, and the final delivery of intricate finished products.
With a laser-sharp focus on complex orthopedic implants, SpiTrex Orthopedics stands as a global contract manufacturer of note. Their specialization caters to the Spine, Trauma, and Extremity markets. The inclusion of Watershed Idea Foundry’s additive manufacturing prowess within the SpiTrex ecosystem positions them at the intersection of innovation and excellence. This amalgamation of expertise augurs well for the medical device industry, promising a future where cutting-edge technology converges seamlessly with healthcare solutions. As SpiTrex Orthopedics continues to pave the way for advancement, the acquisition of Watershed Idea Foundry marks a significant stride in their journey toward global leadership in contract manufacturing and additive manufacturing technologies.